United-Guardian, Inc.  

(Public, NASDAQ:UG)   Watch this stock  
Find more results for UG
18.94
+0.29 (1.55%)
Apr 1 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 18.51 - 18.94
52 week 17.55 - 35.25
Open 18.51
Vol / Avg. 2,707.00/7,964.00
Mkt cap 85.72M
P/E 21.49
Div/yield 0.32/4.22
EPS 0.88
Shares 4.60M
Beta -0.02
Inst. own 18%
May 5, 2015
Q1 2015 United-Guardian Inc Earnings Release (Estimated) Add to calendar
Mar 23, 2015
Q4 2014 United-Guardian Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 35.11% 30.12%
Operating margin 44.68% 41.01%
EBITD margin - 42.17%
Return on average assets 35.29% 25.64%
Return on average equity 38.10% 27.96%
Employees 33 -
CDP Score - -

Address

230 Marcus Blvd.
HAUPPAUGE, NY 11788
United States - Map
+1-631-2730900 (Phone)
+1-631-2730858 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

United-Guardian, Inc. is an integrated research, development, manufacturing, and marketing company. The Company supply products to the personal care, health care, industrial, and pharmaceutical sectors. The company's products are developed and manufactured by its Guardian Laboratories Division. The personal care and cosmetic ingredients are marketed through a worldwide network of marketing partners and distributors. The pharmaceuticals are sold to full-line drug wholesalers, which distribute them to pharmacies, hospitals, physicians, long-term care facilities, and other health care providers. The health care products are marketed to manufacturers of medical devices and other medical products, which incorporate them into their finished products and distribute them to hospitals, pharmacies, and other health care facilities. The Company´┐Żs two major product lines, Lubrajel and Renacidin Irrigation (Renacidin) together accounted for 94.4% of revenue as of December 31, 2013.

Officers and directors

Kenneth H. Globus Chairman of the Board, President, General Counsel
Age: 62
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Robert S. Rubinger Chief Financial Officer, Executive Vice President, Treasurer, Secretary, Director
Age: 71
Bio & Compensation  - Reuters
Peter A. Hiltunen Vice President
Age: 55
Bio & Compensation  - Reuters
Joseph J. Vernice Vice President, Manager - Research and Development, Director - Technical Services
Age: 56
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Roseann LaCorte Controller
Age: 47
Bio & Compensation  - Reuters
Andrew A. Boccone Independent Director
Age: 68
Bio & Compensation  - Reuters
Arthur M. Dresner Independent Director
Age: 72
Bio & Compensation  - Reuters
Lawrence F. Maietta Independent Director
Age: 56
Bio & Compensation  - Reuters
Christopher W. Nolan Sr. Independent Director
Age: 49
Bio & Compensation  - Reuters